Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

Scientists report regional changes in brain gray matter density in patients with IBS

Aug. 6, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

DAB2IP gene SNP correlates with susceptibility to abdominal aortic aneurism

Aug. 4, 2010

IGFBP-7 mediates oncogene-induced senescence in papillary thyroid carcinoma

Aug. 4, 2010

Reduced TSPO expression and low progesterone are linked to MDD

Aug. 3, 2010

Quest Diagnostics' XSense test for fragile X syndrome approved in New York state

Aug. 3, 2010

Methylation state of HOXD3 gene identified as biomarker for prostate cancer

Aug. 3, 2010

Prolactin receptor expression is potential biomarker for colorectal cancer progression

Aug. 3, 2010

Sexual dysfunction in schizophrenia linked to typical antipsychotics, prolactin and DRD2 genotype

Aug. 2, 2010

SLC22A4, SLC22A5 and KIF3A SNPs linked to tuberculosis in Thai population

July 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...